In the original version of this article (1), an error in Fig. 6C was introduced by the compositor during the production of the paper. Specifically, the Raptor Western blot was improperly shifted. The figure has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets the error.
References
1.
Teh
JLF
, Cheng
PF
, Purwin
TJ
, Nikbakht
N
, Patel
P
, Chervoneva
I
, et al In vivo E2F reporting reveals efficacious schedules of MEK1/2-CDK4/6 targeting and mTOR-S6 resistance mechanisms
. Cancer Discov
2018
;8
:568
–81
.©2018 American Association for Cancer Research.
2018
American Association for Cancer Research.